Flow measurement before and after papaverine injection in above-knee prosthetic femoropopliteal bypass Gustav Pedersen, MD, Elin Laxdal, MD, Svein Roar.

Slides:

Advertisements

Similar presentations

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:

Advertisements

Richard M. Green, MD, William M

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions

Autologous alternative veins may not provide better outcomes than prosthetic conduits for below-knee bypass when great saphenous vein is unavailable

Peter J. Fahner, MD, Mirza M. Idu, MD, PhD, Thomas M

Stenting of femoropopliteal lesions using interwoven nitinol stents

Outcome of infra-inguinal bypass grafts using vein conduit with less than 3 millimeters diameter in critical leg ischemia Hani Slim, MD, MRCS, Alok Tiwari,

Tim J. van Oostenbrugge, MD, Jean-Paul P. M

Vein harvesting technique for infrainguinal arterial bypass with great saphenous vein and its association with surgical site infection and graft patency

Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation Thomas M. Loh,

Lower extremity arterial revascularization using conditioned small-diameter great saphenous vein Maher Fattoum, MD, Stefan Kennel, MD, Peter Knez, MD,

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial Jill.

The learning curve of robot-assisted laparoscopic aortofemoral bypass grafting for aortoiliac occlusive disease Tomáš Novotný, MD, Martin Dvořák, MD,

The impact of gender on outcome after infrainguinal arterial reconstructions for peripheral occlusive disease Enzo Ballotta, MD, Mario Gruppo, MD, Renata.

Durability of the in situ saphenous vein arterial bypass: A comparison of primary and secondary patency Dennis F. Bandyk, M.D., Hermann W. Kaebnick,

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization Gregory S. Cherr, MD, Jiping Wang, MD,

Axillopopliteal bypass for limb salvage

Edmond J. Prendiville, MB, FRCSI, Anson Yeager, MD, Thomas F

Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease Jean-Baptiste Ricco,

Infrainguinal revascularizations in octogenarians and septuagenarians

A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access Evan R. Brownie,

Thrombolysis for lower extremity bypass graft occlusion

Cryopreserved saphenous vein graft in infrainguinal bypass

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass James T. McPhee, MD, Neal R. Barshes, MD,

A prospective randomized trial comparing vein with polytetrafluoroethylene in above- knee femoropopliteal bypass grafting Desiree H.C. Burger, MDa, A.Pieter.

Predictive factors for better bypass patency and limb salvage after prosthetic above- knee bypass reconstruction Eric Klingelhoefer, MD, Hendrik Bergert,

Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W

A comparison of tibial artery bypass performed with heparin-bonded expanded polytetrafluoroethylene and great saphenous vein to treat critical limb ischemia

W. Anthony Lee, MD, Peter R. Nelson, MD, Scott A

Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures Hans Schweiger, MD,

A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease Norman R.

Peter Neglén, MD, PhD, Kathryn C. Hollis, BA, Seshadri Raju, MD

Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass Afshin Assadian, MD, Hans-Henning Eckstein, MD Afshin Assadian, MD, Felix Härtl,

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, Clinton D. Protack,

Lewis B. Schwartz, MD, Michael Belkin, MD, Magruder C

Ilia Gur, MD, William Lee, MD, Gabriel Akopian, MD, Vincent L

Reply Journal of Vascular Surgery

Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease Robert W. Chang, MD, Philip P. Goodney,

The influence of gender on patency rates after iliac artery stenting

Paclitaxel-coated versus plain balloon angioplasty in the treatment of infrainguinal vein bypass stenosis Klaus Linni, MD, Ara Ugurluoglu, MD, Manuela.

Prospective, randomized comparison of ringed and nonringed polytetrafluoroethylene femoropopliteal bypass grafts: A preliminary report Sushil K. Gupta,

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency Carlos Eduardo Pereira, MD, Maximiano Albers, MD, PhD, Marcello.

Javier G. Jimenez, MD, Thomas S. Huber, MD, PhD, C

Joseph R. Schneider, MD, PhD, Martha D. McDaniel, MD, Daniel B

Composite sequential bypasses to the ankle and beyond for limb salvage

Reconstructive surgery for complex aortoiliac occlusive disease in young adults Enzo Ballotta, MD, Renata Lorenzetti, MD, Giacomo Piatto, MD, Francesca.

Carlos H. Timaran, MD, Scott L. Stevens, MD, Oscar H

Donald T. Baril, MD, Luke K. Marone, MD, Justine Kim, Michael R

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

Creating functional autogenous vascular access in older patients

Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: Six-year results of a randomized clinical trial Gijs J. Aalders,

The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure Robert Scott Brumberg, DO, Martin R. Back,

Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a.

Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia Catherine K. Chang, MD, Salvatore.

Femorofemoral bypass with femoral popliteal vein

Bhagwan Satiani, MD, MBA, Thomas E. Williams, MD, PhD, Michael R

Long-term results of arterial allograft below-knee bypass grafts for limb salvage: A retrospective multicenter study J.N. Albertini, MD, X. Barral, MD,

Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes William P. Robinson, MD, Louis L.

Endovascular interventions for TASC II D femoropopliteal lesions

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Randomized comparison of 6-mm straight grafts versus 6- to 8-mm tapered grafts for brachial-axillary dialysis access Jose R. Polo, MD, PhD, Jose M. Ligero,

Luke S. Erdoes, MD, Timothy P. Milner, MD Journal of Vascular Surgery

Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance Lawrence Oresanya, MD, Anil N. Makam,

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

Flow measurement before and after papaverine injection in above-knee prosthetic femoropopliteal bypass Gustav Pedersen, MD, Elin Laxdal, MD, Svein Roar Amundsen, MD, Einar Dregelid, MD, Torbjørn Jonung, MD, PhD, Thomas Nyheim, MD, Steinar Aune, MD, PhD Journal of Vascular Surgery Volume 43, Issue 4, Pages 729-734 (April 2006) DOI: 10.1016/j.jvs.2005.12.041 Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

Fig 1 The primary assisted patency rates of 87 above-knee femoropopliteal prostheses. The numbers below the curve indicate the numbers at risk. Journal of Vascular Surgery 2006 43, 729-734DOI: (10.1016/j.jvs.2005.12.041) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

Fig 2 The distribution of intraoperative basal flow measurements in 87 above-knee prosthetic femoropopliteal bypass operations. The flow measurements are categorized as hundreds of milliliters per minute, rounding off downwards. Journal of Vascular Surgery 2006 43, 729-734DOI: (10.1016/j.jvs.2005.12.041) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

Fig 3 The distribution of papaverine flow measurements in 87 operations. The flow measurements are categorized as hundreds of milliliters per minute, rounding off downwards. Journal of Vascular Surgery 2006 43, 729-734DOI: (10.1016/j.jvs.2005.12.041) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

Fig 4 The primary patency rates of 59 grafts with a papaverine flow <500 mL/min and 28 grafts with a papaverine flow >500 mL/min. The numbers above and below the curves indicate the numbers at risk. The differences in patency rates are significant (P = .03, log-rank test). The median patency (time to reach 50% occlusion rate) for grafts with papaverine flow ≥500 mL/min is 48 months (SEM, 6.7; 95% confidence interval, 35 to 61). The median patency for grafts with papaverine flow <500 mL/min is 30 months (SEM, 4.3; 95% confidence interval, 21 to 38). Journal of Vascular Surgery 2006 43, 729-734DOI: (10.1016/j.jvs.2005.12.041) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions